| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 10326-21-3 | Chloric acid magnesium salt | |
Cl2MgO6 | 191.21 |
| 103255-85-2 | 4-piperidinone, 1-((2-(7-chloro-5-methyl-1,8-naphthyridin-2-yl)-2,3-dihydro-3-o | |
| |
| 103255-84-1 | 1,4-dioxa-8-azaspiro(4.5)decane, 8-((2-(7-chloro-5-methyl-1,8-naphthyridin-2-yl | |
| |
| 103255-83-0 | ndol-1- yl)acetyl)- | |
| |
| 103255-82-9 | 4-piperidinone, 1-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-5-nitro-3-ox | |
| |
| 103255-81-8 | propanoate (ester) | |
| |
| 103255-80-7 | 4-piperidinol, 1-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-oxo-1h-isoi | |
| |
| 103255-79-4 | ydro-5-nitro- 3-oxo-1h-isoindol-1-yl)acetyl)- | |
| |
| 103255-78-3 | ydro-6-nitro- 3-oxo-1h-isoindol-1-yl)acetyl)- | |
| |
| 103255-77-2 | 1,4-dioxa-8-azaspiro(4.5)decane, 8-((6-chloro-2-(7-chloro-1,8-naphthyridin-2-yl | |
| |
| 103255-76-1 | 4-piperidinone, 1-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-6-nitro-3-ox | |
| |
| 103255-75-0 | 4-piperidinone, 1-((6-chloro-2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-o | |
| |
| 103255-74-9 | 1,4-dithia-8-azaspiro(4.5)decane, 8-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-di | |
| |
| 103255-73-8 | 9-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-5-dithia-9-azaspiro(5.5)undecane | |
| |
| 103255-72-7 | ihydro-3-oxo- 1h-isoindol-1-yl)acetyl)- | |
| |
| 103255-71-6 | 1,5-dioxa-9-azaspiro(5.5)undecane, 9-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-d | |
| |
| 103255-70-5 | 4-diethoxy-l-1- yl)acetyl)- | |
| |
| 103255-69-2 | piperidine, 1-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-oxo-1h-isoindo | |
| |
| 103255-68-1 | indol-1- yl)acetyl)- | |
| |
| 103255-67-0 | 4-piperidinone, 1-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3-oxo-1h-iso | |
| |
| 103255-66-9 | 1,4-dioxa-8-azaspiro(4.5)decane, 8-((2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dih | |
| |
| 103255-65-8 | 1-((2,3-dihydro-2-(4-methoxyphenyl)-6-nitro-3-oxo-1h-isoindol-1-4-piperidino | |
| |
| 103255-64-7 | 4-piperidinol, 1-((6-chloro-2,3-dihydro-2-(4-methoxyphenyl)-3-oxo-1h-isoindol-1 | |
| |
| 103255-63-6 | 1-((2,3-dihydro-2-(4-methoxyphenyl)-6-nitro-3-oxo-1h-isoindol-1-yl)acetyl) -4-piperidinon 4-oxime | |
| |
| 103255-62-5 | 4-piperidinone, 1-((2,3-dihydro-2-(4-methoxyphenyl)-6-nitro-3-oxo-1h-isoindol-1 | |
| |
| 103255-61-4 | 1,4-dioxa-8-azaspiro(4,5)decane, 8-((2,3-dihydro-2-(4-methoxyphenyl)-3-oxo-1h-i | |
| |
| 103255-60-3 | 5)decane, 8-((2,3-dihydro-2-(4-methoxyphenyl)-6-nitro-3-4-dioxa-8-azaspiro(4 | |
| |
| 41661-47-6 | 1-yl)acetyl )- | |
C5H9NO | 99.13 |
| 103255-58-9 | 1-((6-chloro-2,3-dihydro-2-(4-methoxyphenyl)-3-oxo-1h-isoindol-4-piperidinon | |
| |
| 103255-57-8 | 1,4-dioxa-8-azaspiro(4.5)decane, 8-((6-chloro-2,3-dihydro-2-(4-methoxyphenyl)-3 | |
| |
| 103253-15-2 | l 655240 | |
| |
| 10325-94-7 | 硝酸镉(四水)
Cadmium nitrate | |
Cd·2HNO3 | |
| 10325-79-8 | 5-androsten-3b-ol-17b-carboxylic acid | |
C20H30O3 | 318.45 |
| 103248-88-0 | dibenz(b,f)(1,4)oxazepine-10(11h)-carbothiamide | |
| |
| 103248-26-6 | n-(4-ethoxyphenyl)-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-25-5 | n-(4-methylphenyl)-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-24-4 | n-(4-methoxyphenyl)-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-23-3 | n-(2-methoxyphenyl)-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-22-2 | n-(2-chlorophenyl)-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-21-1 | 6-nitro-n-phenyl-1h-benzimidazole-1-methanamin | |
| |
| 103248-20-0 | 6-nitro-1-(1-pyrrolidinylmethyl)-1h-benzimidazol | |
| |
| 103248-19-7 | 1-(4-morpholinylmethyl)-6-nitro-1h-benzimidazol | |
| |
| 103248-18-6 | 6-nitro-1-(1-piperidinylmethyl)-1h-benzimidazol | |
| |
| 103248-17-5 | 2,2'-(((6-nitro-1h-benzimidazol-1-yl)methyl)imino)bis-ethano | |
| |
| 103248-16-4 | n,n-diethyl-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103248-15-3 | n,n-dimethyl-6-nitro-1h-benzimidazole-1-methanamin | |
| |
| 103245-63-2 | 5-(((aminoiminomethyl)amino)methyl)-2-furancarboxylic aci 6-(aminoiminometh | |
| |
| 103244-43-5 | 1-b)furan, 2,6-dinitro-7-methoxy-naphtho( | |
| |
| 103244-41-3 | insulin-like growth factor ii fragment*33-40 | |
C38H74N20O12 | 1003.13 |
| 103241-64-1 | 2-naphthalenesulfonic acid, 6-amino-5-[[5-chloro-2-(2-chlorophenoxy)phenyl]azo] | |
| |
